Cardlytics (CDLX) Reports Q3 Loss of $0.15
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Cardlytics (CDLX) PT Lowered to $26 at KeyBanc Following 3Q
November 14, 2018 8:22 AM ESTKeyBanc analyst Andy Hargreaves lowered the price target on Cardlytics (NASDAQ: CDLX) to $26.00 (from $28.00) while maintaining a Overweight rating following the company's 3Q. Cardlytics reported mixed 3Q18 results as revenue missed due to advertiser churn, but cost management preserved upside in profitability... More
